Figure legends
Figure 1. The change (reduction) in viral load from baseline on day 3 and day 5 in patients with mild to moderate COVID-19 treated with Azvudine or placebo. (A) Patients with viral load ≥ 3log10 copies/ml. (B) Patients with viral load ≥ 4log10 copies/ml. The P values indicated the differences in the change (reduction) in viral load from baseline on day 5 between the Azvudine group and placebo group.